U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07822529) titled 'A Study of Long Term Persistency of Guselkumab in Adult Participants With Inflammatory Bowel Disease' on Sept. 11.
Brief Summary: The main purpose of this study is to evaluate treatment persistence of guselkumab (that is how long a person keeps taking their prescribed medicine or continues with their treatment plan without stopping) in participants with moderate to severe Crohn's disease (CD) or ulcerative colitis (UC) in real-world setting. CD and UC are inflammatory bowel diseases, a group of inflammatory conditions of the colon and small intestine.
Study Start Date: Sept. 18
Study Type: OBSERVATIONAL
Condition:
Inflammatory ...